Search

everythinglearnresearchcommunity

for

Search:↓

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Chitin and chitosan are useful in cosmetics for oral care, haircare, and skincare, including UV protection and strength improvement.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Vitamin D levels do not affect the risk of developing alopecia areata.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Clinical pharmacists are crucial in improving patient safety by reporting medication errors in hospitals.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Climate-related nutritional stress may cause hair loss in juvenile male Guadalupe fur seals.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.